Atlas Trials

Cadaveric Donor Renal Transplantation

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cadaveric Donor Renal Transplantation

RecordFirmDate
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. (NCT00235300)Genzyme, a Sanofi Company2000-05-01

Track Cadaveric Donor Renal Transplantation automatically

Every clearance here is in the API, with alerts when new ones post.